FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Peter Charles Adamson

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Concepts & Ideas

Procedures

Co-author Network

Publications

TOP 3
Anne B Warwick; Peter Charles Adamson; Matthew M Ames; Richard Gorlick; Mark Krailo; Suman Malempati; Allen Melemed; Stephanie L Safgren; Susan M Blaney
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study.
Yael P Mossé; David T Teachey; Brenda Weigel; Peter Charles Adamson; Charlotte H Ahern; Elizabeth Fox; Mark A Ingle; Emily Lipsitz; John M Maris; Susan M Blaney
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.
BRIGITTE WIDEMANN; Peter Charles Adamson; FRANK BALIS; Sylvain Baruchel; Michael Burke; Elizabeth Fox; Julia Glade Bender; Ashish Ingle; Aerang Kim; Diana Stempak; Brenda J Weigel; Susan M Blaney
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Peter Charles Adamson (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Anne B Warwick; Peter Charles Adamson; Matthew M Ames; Richard Gorlick; Mark Krailo; Suman Malempati; Allen Melemed; Stephanie L Safgren; Susan M Blaney
Phase 2 trial of pemetrexed in children and adolescents with refractory solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2013;60(2):237-41.
2012: Yael P Mossé; David T Teachey; Brenda Weigel; Peter Charles Adamson; Charlotte H Ahern; Elizabeth Fox; Mark A Ingle; Emily Lipsitz; John M Maris; Susan M Blaney
Pediatric phase I trial and pharmacokinetic study of MLN8237, an investigational oral selective small-molecule inhibitor of Aurora kinase A: a Children's Oncology Group Phase I Consortium study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):6058-64.
2012: BRIGITTE WIDEMANN; Peter Charles Adamson; FRANK BALIS; Sylvain Baruchel; Michael Burke; Elizabeth Fox; Julia Glade Bender; Ashish Ingle; Aerang Kim; Diana Stempak; Brenda J Weigel; Susan M Blaney
A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):6011-22.
2012: Julia Glade Bender; Susan M Blaney; Scott Borinstein; Alice Chen; Ashish Ingle; Peter Charles Adamson; Charlotte Ahern; Sylvain Baruchel; Joel M Reid; Brenda J Weigel; Darrell J Yamashiro; Julie R Park
A phase I trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors: a children's oncology group phase I consortium report.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(18):5081-9.
2012: KM Tran; Peter Charles Adamson; David E Cohen; C Dean Kurth; Lynne G Maxwell; Vanessa Moll; Jeffrey L Galinkin
Quantification of serum fentanyl concentrations from umbilical cord blood during ex utero intrapartum therapy.
Anesthesia and analgesia 2012;114(6):1265-7.
2012: Richard Aplenc; David Bertoch; B T Fisher; Robert B Gerbing; M Hall; Y S Huang; R Keren; Y Li; A E Seif; L Sung; Peter Charles Adamson; Todd A Alonzo; Alan S Gamis
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.
Pharmacoepidemiology and drug safety 2012;21 Suppl 2():37-43.
2012: Steven L. Blumer; Peter Charles Adamson; Sudha A Anupindi; Henry Lin; Richard I Markowitz; Anita P Price; Sandra S Kramer
Sporadic adenocarcinoma of the colon in children: case series and review of the literature.
Journal of pediatric hematology/oncology 2012;34(4):e137-41.
2012: Steven G DuBois; Julia Glade-Bender; Ashish M Ingle; Percy Ivy; Joel M Reid; Suzanne Shusterman; Peter Charles Adamson; Charlotte H Ahern; Sylvain Baruchel; Susan M Blaney
Tolerability and pharmacokinetic profile of a sunitinib powder formulation in pediatric patients with refractory solid tumors: a Children's Oncology Group study.
Cancer chemotherapy and pharmacology 2012;69(4):1021-7.
2012: Soheil Meshinchi; Peter Charles Adamson; Richard Aplenc; Stephen P Hunger; J Milburn Jessup
Lessons learned from the investigational device exemption review of Children's Oncology Group trial AAML1031.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(6):1547-54.
2012: Sylvain Baruchel; Peter Charles Adamson; K Scott Baker; Mark Krailo; Michelle Lee-Scott; Alberto Pappo; Doojduen Villaluna; Bing Wu; Susan M Blaney
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology Group.
European journal of cancer (Oxford, England : 1990) 2012;48(4):579-85.
2012: Samara L Poplack Potter; Mark Krailo; Ashish Mark Ingle; Stacey Berg; Peter Charles Adamson; Susan M Blaney
Phase 2 clinical trial of intrathecal topotecan in children with refractory leptomeningeal leukemia: a Children's Oncology Group trial (P9962).
Pediatric blood & cancer 2012;58(3):362-5.
2012: Suman Malempati; Joel M Reid; Charles T Roberts; Stephen Schmechel; Stephan D Voss; Brenda Weigel; Julie M Carroll; Helen X Chen; Steve Y Cho; Ashish Ingle; Mark Krailo; Peter Charles Adamson; Charlotte H Ahern; Susan M Blaney
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012;30(3):256-62.
2011: Robin E Norris; Eric F Rappaport; Peter Charles Adamson
Preclinical evaluation of pemetrexed in pediatric solid tumors.
Pediatric blood & cancer 2011;57(7):1233-5.
2011: Robin E Norris; Garrett M Brodeur; John M Maris; Jane E. Minturn; Peter Charles Adamson
Preclinical evaluation of lestaurtinib (CEP-701) in combination with retinoids for neuroblastoma.
Cancer chemotherapy and pharmacology 2011;68(6):1469-75.
2011: Regina I Jakacki; Ian F Pollack; Stephan D Voss; Peter Charles Adamson; Eric Bouffet; Ashish Ingle; Susan M Blaney
A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study.
Neuro-oncology 2011;13(8):910-5.
2011: Steven G Dubois; Julia Glade-Bender; Holcombe E Grier; Ashish M Ingle; Percy Ivy; Joel M Reid; Suzanne Shusterman; Bing Wu; Peter Charles Adamson; Charlotte H Ahern; Sylvain Baruchel; Susan M Blaney
Phase I and pharmacokinetic study of sunitinib in pediatric patients with refractory solid tumors: a children's oncology group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(15):5113-22.
2011: Richard Aplenc; Susan M Blaney; Lewis C Strauss; FRANK BALIS; Suzanne Shusterman; Ashish Mark Ingle; Shruti Agrawal; Junfeng Sun; John J Wright; Peter Charles Adamson
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortium.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(7):839-44.
2011: Jack Meng Fen Su; Xiao-Nan Li; Patrick Thompson; Ching-Nan Ou; Ashish M Ingle; Heidi Russell; Ching C Lau; Peter Charles Adamson; Susan M Blaney
Phase 1 study of valproic acid in pediatric patients with refractory solid or CNS tumors: a children's oncology group report.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011;17(3):589-97.
2011: BRIGITTE WIDEMANN; Robert J Arceci; Nalini Jayaprakash; Elizabeth Fox; Peter Zannikos; Wendy Goodspeed; Anne Goodwin; John J Wright; Susan M Blaney; Peter Charles Adamson; FRANK BALIS
Phase 1 trial and pharmacokinetic study of the farnesyl transferase inhibitor tipifarnib in children and adolescents with refractory leukemias: a report from the Children's Oncology Group.
Pediatric blood & cancer 2011;56(2):226-33.
2011: Stacey L Berg; Mitchell S Cairo; Heidi Russell; Janet Ayello; Ashish Mark Ingle; Henry Lau; Nianhang Chen; Peter Charles Adamson; Susan M Blaney
Safety, pharmacokinetics, and immunomodulatory effects of lenalidomide in children and adolescents with relapsed/refractory solid tumors or myelodysplastic syndrome: a Children's Oncology Group Phase I Consortium report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(3):316-23.
2011: Jeffrey S Barrett; Mahesh Narayan; Dimple Patel; Athena F Zuppa; Peter Charles Adamson
Prescribing habits and caregiver satisfaction with resources for dosing children: rationale for more informative dosing guidance.
BMC pediatrics 2011;11():25.
2010: Abdul-Kader Souid; Ronald L Dubowy; Ashish M Ingle; Maureen G Conlan; Junfeng Sun; Susan M Blaney; Peter Charles Adamson
A pediatric phase I trial and pharmacokinetic study of ispinesib: a Children's Oncology Group phase I consortium study.
Pediatric blood & cancer 2010;55(7):1323-8.
2010: Elizabeth Fox; Richard Aplenc; Rochelle Bagatell; Meredith K Chuk; Eva Dombi; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Nalini Jayaprakash; Marcelo Marotti; Kathryn H Brown; Barbara Wenrich; Peter Charles Adamson; BRIGITTE WIDEMANN; FRANK BALIS
A phase 1 trial and pharmacokinetic study of cediranib, an orally bioavailable pan-vascular endothelial growth factor receptor inhibitor, in children and adolescents with refractory solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(35):5174-81.
2010: Jeffrey M Skolnik; Alena Y Zhang; Jeffrey S Barrett; Peter Charles Adamson
Approaches to clear residual chemotherapeutics from indwelling catheters in children with cancer.
Therapeutic drug monitoring 2010;32(6):741-8.
2010: Rani E George; Jill Lahti; Peter Charles Adamson; Kejin Zhu; David Finkelstein; A Mark Ingle; Joel M Reid; Mark Krailo; Donna Neuberg; Susan M Blaney; Lisa Diller
Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2010;55(4):629-38.
2010: Emily Lipsitz; Ganesh Moorthy; Yael Mosse; Elizabeth Fox; Peter Charles Adamson
A sensitive and selective liquid chromatography/tandem mass spectrometry method for determination of MLN8237 in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2010;878(25):2369-73.
2010: BRIGITTE WIDEMANN; FRANK BALIS; AeRang Kim; Matthew Boron; Nalini Jayaprakash; Aiman Shalabi; Michelle O'Brien; Michelle Eby; Diane E Cole; RF Murphy; Elizabeth Fox; Percy Ivy; Peter Charles Adamson
Glucarpidase, leucovorin, and thymidine for high-dose methotrexate-induced renal dysfunction: clinical and pharmacologic factors affecting outcome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(25):3979-86.
2010: Orren Beaty; Stacey Berg; Susan M Blaney; Marcio Malogolowkin; Mark Krailo; Ronald Knight; Paula Schaiquevich; Clinton Stewart; Zhengjia Chen; Marvin Nelson; Stephan Voss; S Percy Ivy; Peter Charles Adamson
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2010;55(3):440-5.
2010: Elizabeth Fox; John M Maris; Susan Cohn; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Diane Medina; Hao Xiong; Andrew Krivoshik; BRIGITTE WIDEMANN; Peter Charles Adamson; FRANK BALIS
Pharmacokinetics of orally administered ABT-751 in children with neuroblastoma and other solid tumors.
Cancer chemotherapy and pharmacology 2010;66(4):737-43.
2010: Maryam Fouladi; Julie R Park; Clinton F Stewart; Richard J Gilbertson; Paula Schaiquevich; Junfeng Sun; Joel M Reid; Matthew M Ames; Roseanne Speights; Ashish M Ingle; James Zwiebel; Susan M Blaney; Peter Charles Adamson
Pediatric phase I trial and pharmacokinetic study of vorinostat: a Children's Oncology Group phase I consortium report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(22):3623-9.
2010: Stacey L Berg; Naomi J Winick; Ashish Ingle; Peter Charles Adamson; Susan M Blaney
Reasons for participation in optional pharmacokinetic studies in children with cancer: a Children's Oncology Group phase 1 consortium study.
Pediatric blood & cancer 2010;55(1):119-22.
2010: Felice Su; Susan C Nicolson; Marc R Gastonguay; Jeffrey S Barrett; Peter Charles Adamson; David S Kang; Rodolfo I Godinez; Athena F Zuppa
Population pharmacokinetics of dexmedetomidine in infants after open heart surgery.
Anesthesia and analgesia 2010;110(5):1383-92.
2010: Robin E Norris; Peter Charles Adamson
Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias.
Cancer chemotherapy and pharmacology 2010;65(6):1125-30.
2010: Lars M Wagner; John P Perentesis; Joel M Reid; Matthew M Ames; Stephanie L Safgren; Marvin D Nelson; Ashish M Ingle; Susan M Blaney; Peter Charles Adamson
Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: a Children's Oncology Group phase I consortium study.
Pediatric blood & cancer 2010;54(4):538-45.
2010: Tracy A Glauser; Avital Cnaan; Shlomo Shinnar; Deborah G Hirtz; Dennis Dlugos; David Masur; Peggy O Clark; Edmund V Capparelli; Peter Charles Adamson
Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy.
The New England journal of medicine 2010;362(9):790-9.
2010: Peter Charles Adamson
It's not easy being small.
Pediatric blood & cancer 2010;54(3):341-3.
2010: Shana Jacobs; Elizabeth Fox; Mark Krailo; Gwen Hartley; Fariba Navid; Leonard H Wexler; Susan M Blaney; Anne Goodwin; Wendy Goodspeed; FRANK BALIS; Peter Charles Adamson; BRIGITTE WIDEMANN
Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(2):750-4.
2010: John T Mondick; Brendan M Johnson; Lynda J Haberer; Mark E Sale; Peter Charles Adamson; Charles J Coté; James M Croop; Mark W Russo; Jeffrey S Barrett; J Frank Hoke
Population pharmacokinetics of intravenous ondansetron in oncology and surgical patients aged 1-48 months.
European journal of clinical pharmacology 2010;66(1):77-86.
2009: Anne L Angiolillo; Alice L Yu; Gregory H Reaman; Ashish Ingle; Rita Secola; Peter Charles Adamson
A phase II study of Campath-1H in children with relapsed or refractory acute lymphoblastic leukemia: a Children's Oncology Group report.
Pediatric blood & cancer 2009;53(6):978-83.
2009: Kelly C Wade; Daniel K Benjamin; David A Kaufman; Robert M Ward; Phillip B Smith; Bhuvana Jayaraman; Peter Charles Adamson; Marc R Gastonguay; Dustin Paul
Fluconazole dosing for the prevention or treatment of invasive candidiasis in young infants.
The Pediatric infectious disease journal 2009;28(8):717-23.
2009: Lisa M McGregor; Sheri L Spunt; Wayne L Furman; Clinton F Stewart; Paula Schaiquevich; Mark Krailo; Rose Anne Speights; Percy Ivy; Peter Charles Adamson; Susan M Blaney
Phase 1 study of oxaliplatin and irinotecan in pediatric patients with refractory solid tumors: a children's oncology group study.
Cancer 2009;115(8):1765-75.
2009: Michael Neely; Hasan Jafri; Nita L Seibel; Katherine Knapp; Peter Charles Adamson; Susan K Bradshaw; Kim M Strohmaier; Peng Sun; Sheng Bi; Marissa Fallon Dockendorf; Julie A Stone; Nicholas A Kartsonis
Pharmacokinetics and safety of caspofungin in older infants and toddlers.
Antimicrobial agents and chemotherapy 2009;53(4):1450-6.
2009: FRANK BALIS; E Fox; BRIGITTE WIDEMANN; Peter Charles Adamson
Clinical drug development for childhood cancers.
Clinical pharmacology and therapeutics 2009;85(2):127-9.
2009: Peter Charles Adamson
Imaging in early phase childhood cancer trials.
Pediatric radiology 2009;39 Suppl 1():S38-41.
2008: Peter Charles Adamson
Current challenges in pediatric drug development.
Clinical advances in hematology & oncology : H&O 2008;6(12):883-4.
2008: Js Barrett; Jm Skolnik; B Jayaraman; D Patel; Peter Charles Adamson
Discrete event simulation applied to pediatric phase I oncology designs.
Clinical pharmacology and therapeutics 2008;84(6):729-33.
2008: K C Wade; D Wu; D A Kaufman; R M Ward; D K Benjamin; J E Sullivan; N Ramey; B Jayaraman; K Hoppu; Peter Charles Adamson; Marc R Gastonguay; Dustin Paul
Population pharmacokinetics of fluconazole in young infants.
Antimicrobial agents and chemotherapy 2008;52(11):4043-9.
2008: Regina I Jakacki; Marta Hamilton; Richard J Gilbertson; Susan M Blaney; Jean Tersak; Mark D Krailo; Ashish Ingle; Stephan D Voss; Janet E Dancey; Peter Charles Adamson
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(30):4921-7.
2008: Kristin A Bradley; Ian F Pollack; Joel M Reid; Peter Charles Adamson; Matthew M Ames; Gilbert Vezina; Susan Blaney; Percy Ivy; Tianni Zhou; Mark Krailo; Gregory Reaman; Minesh Mehta
Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.
Neuro-oncology 2008;10(5):752-8.
2008: Sarah Tabbutt; Susan C Nicolson; Peter Charles Adamson; Xuemei Zhang; Marc L Hoffman; Winfield Wells; Carl L Backer; Francis X McGowan; James S Tweddell; Paula Bokesch; Mark Schreiner
The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial.
The Journal of thoracic and cardiovascular surgery 2008;136(2):321-8.
2008: Elizabeth A Raetz; Mitchell S Cairo; Michael J Borowitz; Susan M Blaney; Mark D Krailo; Tarek A Leil; Joel M Reid; David M Goldenberg; William A Wegener; William L Carroll; Peter Charles Adamson
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(22):3756-62.
2008: Regina I Jakacki; Allan Yates; Susan M Blaney; Tianni Zhou; Robert D Timmerman; Ashish Ingle; Lynda Flom; Michael D Prados; Peter Charles Adamson; Ian F Pollack
A phase I trial of temozolomide and lomustine in newly diagnosed high-grade gliomas of childhood.
Neuro-oncology 2008;10(4):569-76.
2008: Aerang Kim; Elizabeth Fox; Katherine Warren; Susan M Blaney; Stacey L Berg; Peter Charles Adamson; Madeleine Libucha; Elena Byrley; FRANK BALIS; BRIGITTE WIDEMANN
Characteristics and outcome of pediatric patients enrolled in phase I oncology trials.
The oncologist 2008;13(6):679-89.
2008: Blaine W Robinson; Kathryn C Behling; Manish Gupta; Alena Y Zhang; Jonni S Moore; Andrew D Bantly; Cheryl L Willman; Andrew J Carroll; Peter Charles Adamson; Jeffrey S Barrett; Carolyn A Felix
Abundant anti-apoptotic BCL-2 is a molecular target in leukaemias with t(4;11) translocation.
British journal of haematology 2008;141(6):827-39.
2008: Peter Charles Adamson; Jeffrey S Barrett
All dex'ed out with nowhere to go?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(12):1917-8.
2008: Janet L Franklin; Nita L Seibel; Mark Krailo; Cecilia Fu; Peter Charles Adamson; Gregory Reaman
Phase 2 study of docetaxel in the treatment of childhood refractory acute leukemias: a Children's Oncology Group report.
Pediatric blood & cancer 2008;50(3):533-6.
2008: Anne-Marie Langevin; Mark Bernstein; John Kuhn; Susan M Blaney; Percy Ivy; Junfeng Sun; Zhengjia Chen; Peter Charles Adamson
A phase II trial of rebeccamycin analogue (NSC #655649) in children with solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2008;50(3):577-80.
2008: Elizabeth Fox; John M Maris; BRIGITTE WIDEMANN; Wendy Goodspeed; Anne Goodwin; Marie Kromplewski; Molly E Fouts; Diane Medina; Susan Cohn; Andrew Krivoshik; Anne Hagey; Peter Charles Adamson; FRANK BALIS
A phase I study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 21 days every 28 days in pediatric patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1111-5.
2008: James I Lee; Vu T Nguyen; Mei-Ling Chen; Peter Charles Adamson
A rapid, sensitive and selective liquid chromatography/atmospheric pressure chemical ionization tandem mass spectrometry method for determination of fenretinide (4-HPR) in plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;862(1-2):64-71.
2008: Mason Bond; Mark L Bernstein; Alberto Pappo; Kirk R Schultz; Mark Krailo; Susan M Blaney; Peter Charles Adamson
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2008;50(2):254-8.
2008: Julia L Glade Bender; Peter Charles Adamson; Joel M Reid; Lu Xu; Sylvain Baruchel; Yuval Shaked; Robert S Kerbel; Erin M Cooney-Qualter; Diana Stempak; Helen X Chen; Marvin D Nelson; Mark Krailo; Ashish Ingle; Susan M Blaney; Jessica J Kandel; Darrell J Yamashiro
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):399-405.
2008: Elizabeth Fox; Bassem I Razzouk; BRIGITTE WIDEMANN; Shaun Xiao; Michelle O'Brien; Wendy Goodspeed; Gregory H Reaman; Susan M Blaney; Anthony J Murgo; FRANK BALIS; Peter Charles Adamson
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma.
Blood 2008;111(2):566-73.
2008: Jeffrey M Skolnik; Jeffrey S Barrett; Bhuvana Jayaraman; Dimple Patel; Peter Charles Adamson
Shortening the timeline of pediatric phase I trials: the rolling six design.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(2):190-5.
2008: John T Mondick; Leonid Gibiansky; Marc R Gastonguay; Jeffrey M Skolnik; Michael Cole; Gareth Veal; Alan V Boddy; Peter Charles Adamson; Jeffrey S Barrett
Population pharmacokinetic investigation of actinomycin-D in children and young adults.
Journal of clinical pharmacology 2008;48(1):35-42.
2008: Mark J Ratain; Rachel W Humphrey; Gary B Gordon; Gwen Fyfe; Peter Charles Adamson; Thomas R Fleming; Walter M Stadler; Donald A Berry; Carl C Peck
Recommended changes to oncology clinical trial design: revolution or evolution?
European journal of cancer (Oxford, England : 1990) 2008;44(1):8-11.
2008: Peter Charles Adamson
Stress lysis in childhood leukemia.
Pediatric blood & cancer 2008;50(1):137-9.
2007: Terzah M Horton; Patrick A Thompson; Stacey L Berg; Peter Charles Adamson; Ashish Ingle; M Eileen Dolan; Shannon M Delaney; Madhuri Hedge; Heidi L Weiss; Meng-Fen Wu; Susan M Blaney
Phase I pharmacokinetic and pharmacodynamic study of temozolomide in pediatric patients with refractory or recurrent leukemia: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(31):4922-8.
2007: Jeffrey Blumer; Stacey Berg; Peter Charles Adamson; Thomas Loew; Greg Rossi; Caroline Hastings
Pharmacokinetic evaluation of darbepoetin alfa for the treatment of pediatric patients with chemotherapy-induced anemia.
Pediatric blood & cancer 2007;49(5):687-93.
2007: Peter Charles Adamson; Katherine K Matthay; Michelle O'Brien; Gregory H Reaman; Judith K Sato; FRANK BALIS
A phase 2 trial of all-trans-retinoic acid in combination with interferon-alpha2a in children with recurrent neuroblastoma or Wilms tumor: A Pediatric Oncology Branch, NCI and Children's Oncology Group Study.
Pediatric blood & cancer 2007;49(5):661-5.
2007: Lisa R Bomgaars; Mark Bernstein; Mark Krailo; Richard Kadota; Soma Das; Zhengjia Chen; Peter Charles Adamson; Susan M Blaney
Phase II trial of irinotecan in children with refractory solid tumors: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(29):4622-7.
2007: Erin Cooney-Qualter; Mark Krailo; Anne L Angiolillo; Rashid Fawwaz; Gregory Wiseman; Lauren Harrison; Virginia Kohl; Peter Charles Adamson; Janet Ayello; Carmella vande Ven; Sherrie L Perkins; Mitchell S Cairo
A phase I study of 90yttrium-ibritumomab-tiuxetan in children and adolescents with relapsed/refractory CD20-positive non-Hodgkin's lymphoma: a Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(18 Pt 2):5652s-5660s.
2007: Shana S Jacobs; Linda C Stork; Bruce C Bostrom; Raymond J Hutchinson; John Holcenberg; Gregory H Reaman; Gary R Erdmann; Janet Franklin; Joseph P Neglia; Seth M Steinberg; FRANK BALIS; Peter Charles Adamson
Substitution of oral and intravenous thioguanine for mercaptopurine in a treatment regimen for children with standard risk acute lymphoblastic leukemia: a collaborative Children's Oncology Group/National Cancer Institute pilot trial (CCG-1942).
Pediatric blood & cancer 2007;49(3):250-5.
2007: Antonio Jimeno; Najat C Daw; Maria L Amador; George Cusatis; Piotr Kulesza; Mark Krailo; Ashish Ingle; Susan M Blaney; Peter Charles Adamson; Manuel Hidalgo
Analysis of biologic surrogate markers from a Children's Oncology Group Phase I trial of gefitinib in pediatric patients with solid tumors.
Pediatric blood & cancer 2007;49(3):352-7.
2007: James I Lee; Jeffrey M Skolnik; Jeffrey S Barrett; Peter Charles Adamson
A sensitive and selective liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer.
Journal of mass spectrometry : JMS 2007;42(6):761-70.
2007: Susan R Rheingold; Michael D Hogarty; Susan M Blaney; James A Zwiebel; Calies Sauk-Schubert; Reddy Chandula; Mark Krailo; Peter Charles Adamson
Phase I Trial of G3139, a bcl-2 antisense oligonucleotide, combined with doxorubicin and cyclophosphamide in children with relapsed solid tumors: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1512-8.
2007: Suman Malempati; H Stacy Nicholson; Joel M Reid; Susan M Blaney; Ashish Ingle; Mark Krailo; Linda C Stork; Allen S Melemed; Renee M McGovern; Stephanie L Safgren; Matthew M Ames; Peter Charles Adamson
Phase I trial and pharmacokinetic study of pemetrexed in children with refractory solid tumors: the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(12):1505-11.
2007: Felice Su; Athena F Zuppa; Peter Charles Adamson
Untying the Gordian knot.
Anesthesia and analgesia 2007;104(4):993; author reply 993-4.
2007: Brenda J Weigel; Susan M Blaney; Joel M Reid; Stephanie L Safgren; Rochelle Bagatell; John H Kersey; Joseph P Neglia; S Percy Ivy; Ashish Ingle; Luke Whitesell; Richard J Gilbertson; Mark Krailo; Matthew Ames; Peter Charles Adamson
A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: a Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(6):1789-93.
2007: Terzah M Horton; Debananda Pati; Sharon E Plon; Patrick A Thompson; Lisa R Bomgaars; Peter Charles Adamson; Ashish Ingle; John Wright; Adam H Brockman; Martin Paton; Susan M Blaney
A phase 1 study of the proteasome inhibitor bortezomib in pediatric patients with refractory leukemia: a Children's Oncology Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(5):1516-22.
2007: Jeffrey M Skolnik; Peter Charles Adamson
Tyrosine kinase inhibitors in pediatric malignancies.
Cancer investigation 2007;25(7):606-12.
2006: Douglas S Hawkins; Scott Bradfield; James A Whitlock; Mark Krailo; Janet Franklin; Susan M Blaney; Peter Charles Adamson; Gregory Reaman
Topotecan by 21-day continuous infusion in children with relapsed or refractory solid tumors: a Children's Oncology Group study.
Pediatric blood & cancer 2006;47(6):790-4.
2006: Elizabeth Fox; John M Maris; BRIGITTE WIDEMANN; Kysa Meek; Anne Goodwin; Wendy Goodspeed; Marie Kromplewski; Molly E Fouts; Diane Medina; Steve Y Cho; Susan Cohn; Andrew Krivoshik; Anne Hagey; Peter Charles Adamson; FRANK BALIS
A phase 1 study of ABT-751, an orally bioavailable tubulin inhibitor, administered daily for 7 days every 21 days in pediatric patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(16):4882-7.
2006: Maryam Fouladi; Wayne L Furman; Thomas Chin; Burgess B Freeman; Lorina Dudkin; Clinton F Stewart; Mark Krailo; Rose Anne Speights; Ashish Ingle; Peter J Houghton; John Wright; Peter Charles Adamson; Susan M Blaney
Phase I study of depsipeptide in pediatric patients with refractory solid tumors: a Children's Oncology Group report.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3678-85.
2006: Peter Charles Adamson; Larry A Rhodes; J Philip Saul; Macdonald Dick II; Michael R Epstein; Peter Moate; Ray Boston; Mark S Schreiner
The pharmacokinetics of esmolol in pediatric subjects with supraventricular arrhythmias.
Pediatric cardiology 2006;27(4):420-7.
2006: BRIGITTE WIDEMANN; Peter Charles Adamson
Understanding and managing methotrexate nephrotoxicity.
The oncologist 2006;11(6):694-703.
2006: Athena F Zuppa; Susan C Nicolson; Peter Charles Adamson; Gil Wernovsky; John T Mondick; Nancy B Burnham; Timothy M Hoffman; J William Gaynor; Lauren A Davis; William J Greeley; Thomas L Spray; Jeffrey S Barrett
Population pharmacokinetics of milrinone in neonates with hypoplastic left heart syndrome undergoing stage I reconstruction.
Anesthesia and analgesia 2006;102(4):1062-9.
2006: Jeffrey M Skolnik; Jeffrey S Barrett; Heng Shi; Peter Charles Adamson
A liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of actinomycin-D and vincristine in children with cancer.
Cancer chemotherapy and pharmacology 2006;57(4):458-64.
2006: Kaci L Osenga; Jacquelyn A Hank; Mark R Albertini; Jacek Gan; Adam G Sternberg; Jens Eickhoff; Robert C Seeger; Katherine K Matthay; Charles Patrick Reynolds; Clare Twist; Mark Krailo; Peter Charles Adamson; Ralph A Reisfeld; Stephen D Gillies; Paul M Sondel
A phase I clinical trial of the hu14.18-IL2 (EMD 273063) as a treatment for children with refractory or recurrent neuroblastoma and melanoma: a study of the Children's Oncology Group.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1750-9.
2006: C Damodar Reddy; asha guttapalli; Peter Charles Adamson; Mohan Vemuri; Donald O'Rourke; Leslie N Sutton; Peter C Phillips
Anticancer effects of fenretinide in human medulloblastoma.
Cancer letters 2006;231(2):262-9.
2005: Debra P Lee; Jeffrey M Skolnik; Peter Charles Adamson
Pediatric phase I trials in oncology: an analysis of study conduct efficiency.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8431-41.
2005: THOMAS WALSH; Peter Charles Adamson; Nita L Seibel; Patricia M Flynn; Michael N Neely; Cindy Schwartz; Aziza Shad; Sheldon L Kaplan; Maureen M Roden; Julie A Stone; Alisha Miller; Susan K Bradshaw; Susan X Li; Carole A Sable; Nicholas A Kartsonis
Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.
Antimicrobial agents and chemotherapy 2005;49(11):4536-45.
2005: Athena F Zuppa; Peter Charles Adamson; John T Mondick; Lauren A Davis; Deborah A Maka; Mahesh Narayan; Charles Nicholson; Dimple Patel; Kathryn R Collison; Jeffrey S Barrett
Drug utilization in the pediatric intensive care unit: monitoring prescribing trends and establishing prioritization of pharmacotherapeutic evaluation of critically ill children.
Journal of clinical pharmacology 2005;45(11):1305-12.
2005: Najat C Daw; Wayne L Furman; Clinton F Stewart; Lisa C Iacono; Mark Krailo; Mark L Bernstein; Janet E Dancey; Rose Anne Speights; Susan M Blaney; James M Croop; Gregory H Reaman; Peter Charles Adamson
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(25):6172-80.
2005: Peter Charles Adamson; Susan M Blaney
New approaches to drug development in pediatric oncology.
Cancer journal (Sudbury, Mass.) 2005;11(4):324-30.
2005: Michael C Stephens; Robert N Baldassano; Amy York; BRIGITTE WIDEMANN; Aaron C Pitney; Nalini Jayaprakash; Peter Charles Adamson
The bioavailability of oral methotrexate in children with inflammatory bowel disease.
Journal of pediatric gastroenterology and nutrition 2005;40(4):445-9.
2005: Susan M Blaney; FRANK BALIS; Stacey Berg; Carola A S Arndt; Richard L Heideman; J Russell Geyer; Roger Packer; Peter Charles Adamson; Kurt A Jaeckle; Renee Klenke; Alberta Aikin; Robert Murphy; Cynthia McCully; David G Poplack
Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(7):1555-63.
2004: Barry D Anderson; Peter Charles Adamson; Susan L Weiner; Mary S McCabe; Malcolm A Smith
Tissue collection for correlative studies in childhood cancer clinical trials: ethical considerations and special imperatives.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4846-50.
2004: Susan M Blaney; Mark Bernstein; Kathleen Neville; Jill P Ginsberg; Brenda Joyce Kitchen; Terzah M Horton; Stacey L Berg; Mark Krailo; Peter Charles Adamson
Phase I study of the proteasome inhibitor bortezomib in pediatric patients with refractory solid tumors: a Children's Oncology Group study (ADVL0015).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(23):4804-9.
2004: Michael J Fisher; Beverly J Lange; Michael Neil Needle; Anna Janss; Hui-Kuo G Shu; Peter Charles Adamson; Peter C Phillips
Amifostine for children with medulloblastoma treated with cisplatin-based chemotherapy.
Pediatric blood & cancer 2004;43(7):780-4.
2004: Athena F Zuppa; Vinay M Nadkarni; Lauren Davis; Peter Charles Adamson; Mark A Helfaer; Michael R Elliott; John Abrams; Dennis R Durbin
The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function.
Critical care medicine 2004;32(11):2318-22.
2004: BRIGITTE WIDEMANN; FRANK BALIS; Aiman Shalabi; Matthew Boron; Michelle O'Brien; Diane E Cole; Nalini Jayaprakash; Percy Ivy; Valerie P Castle; Karin M Muraszko; Christopher L Moertel; Robert Trueworthy; Robert C Hermann; Ali Moussa; Stuart Hinton; Gregory Reaman; David G Poplack; Peter Charles Adamson
Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
Journal of the National Cancer Institute 2004;96(20):1557-9.
2004: Jeffrey L Galinkin; C Dean Kurth; Heng Shi; Margaret A Priestley; Andreas W Loepke; Peter Charles Adamson
The plasma pharmacokinetics and cerebral spinal fluid penetration of intravenous topiramate in newborn pigs.
Biopharmaceutics & drug disposition 2004;25(6):265-71.
2004: THOMAS WALSH; Mats O Karlsson; Timothy Driscoll; Adriano Arguedas; Peter Charles Adamson; Xavier Saez-Llorens; Ajay J Vora; Antonio Arrieta; Jeffrey Blumer; Irja Lutsar; Peter Milligan; Nolan Wood
Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.
Antimicrobial agents and chemotherapy 2004;48(6):2166-72.
2004: Peter Charles Adamson; Susan M Blaney; BRIGITTE WIDEMANN; Brenda Joyce Kitchen; RF Murphy; Alison L Hannah; Gillian F Cropp; M Patel; A F Gillespie; P G Whitcomb; FRANK BALIS
Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.
Cancer chemotherapy and pharmacology 2004;53(6):482-8.
2004: BRIGITTE WIDEMANN; FRANK BALIS; Beate Kempf-Bielack; Stefan S Bielack; Charles B Pratt; Stefano Ferrari; Gaetano Bacci; Alan W Craft; Peter Charles Adamson
High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma.
Cancer 2004;100(10):2222-32.
2004: Tammy Kang; John Dormans; John M Maris; David Carpentieri; Bruce R Pawel; Peter Charles Adamson
Congenital neuroblastoma arising in the deltoid muscle.
Journal of pediatric hematology/oncology 2004;26(2):101-3.
2003: Athena F Zuppa; Heng Shi; Peter Charles Adamson
Liquid chromatography-electrospray mass spectrometry (LC-MS) method for determination of esmolol concentration in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;796(2):293-301.
2003: John C Panetta; Lisa C Iacono; Peter Charles Adamson; Clinton F Stewart
The importance of pharmacokinetic limited sampling models for childhood cancer drug development.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(14):5068-77.
2003: Patrick Thompson; FRANK BALIS; Baruti M Serabe; Stacey Berg; Peter Charles Adamson; Renee Klenke; Alberta Aiken; Roger Packer; Daryl J Murry; Regina I Jakacki; Susan M Blaney
Pharmacokinetics of phenylacetate administered as a 30-min infusion in children with refractory cancer.
Cancer chemotherapy and pharmacology 2003;52(5):417-23.
2003: Giulio J D'Angio; Peter Charles Adamson
A tale of three princes and two physicists--the importance of "why?".
Medical and pediatric oncology 2003;41(2):132-5.
2003: Bulent Ozpolat; Gabriel Lopez-Berestein; Peter Charles Adamson; ChauHwei J Fu; Anthony H Williams
Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 2003;6(2):292-301.
2003: Athena F Zuppa; Mark A Helfaer; Peter Charles Adamson
Propofol pharmacokinetics.
Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies 2003;4(1):124-5.
2003: Susan M Blaney; Richard L Heideman; Stacey Berg; Peter Charles Adamson; Andrea Gillespie; J Russell Geyer; Roger Packer; Kate Matthay; Kurt A Jaeckle; Diane Cole; Nancy Kuttesch; David G Poplack; FRANK BALIS
Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(1):143-7.
2002: Peter J Houghton; Peter Charles Adamson; Susan Blaney; Howard A Fine; Richard Gorlick; Michelle Haber; Lee Helman; Steve Hirschfeld; Melinda G Hollingshead; Mark Israel; Richard B Lock; John M Maris; Glenn Merlino; Wendy Patterson; Charles Patrick Reynolds; Kevin Shannon; Alice L Yu; John Yu; Malcolm A Smith
Testing of new agents in childhood cancer preclinical models: meeting summary.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(12):3646-57.
2002: Michael J Fisher; Peter Charles Adamson
Anti-angiogenic agents for the treatment of brain tumors.
Neuroimaging clinics of North America 2002;12(4):477-99.
2001: Katherine E Warren; M C Patel; Alberta Aikin; BRIGITTE WIDEMANN; Madeleine Libucha; Peter Charles Adamson; R Neuwirth; D Benziger; T O'Toole; K Ford; Nicholas Patronas; Roger J Packer; FRANK BALIS
Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors.
Cancer chemotherapy and pharmacology 2001;48(4):275-82.
2001: Peter Charles Adamson; BRIGITTE WIDEMANN; Gregory H Reaman; Nita L Seibel; RF Murphy; A F Gillespie; FRANK BALIS
A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(10):3034-9.
2001: Wanda L Salzer; BRIGITTE WIDEMANN; Cynthia McCully; Peter Charles Adamson; FRANK BALIS
Effect of probenecid on ventricular cerebrospinal fluid methotrexate pharmacokinetics after intralumbar administration in nonhuman primates.
Cancer chemotherapy and pharmacology 2001;48(3):235-40.
2001: JA Lawrence; Peter Charles Adamson; R Caruso; Catherine Chow; David Kleiner; RF Murphy; David J Venzon; M Shovlin; MH Noone; Maria Merino; Kenneth H Cowan; M Kaiser; Joyce A O'Shaughnessy; Jo Anne Zujewski
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2754-63.
2001: E S Lowe; Brenda Joyce Kitchen; Gary R Erdmann; Linda C Stork; Bruce C Bostrom; Raymond J Hutchinson; John Holcenberg; Gregory H Reaman; W Woods; Janet Franklin; BRIGITTE WIDEMANN; FRANK BALIS; RF Murphy; Peter Charles Adamson
Plasma pharmacokinetics and cerebrospinal fluid penetration of thioguanine in children with acute lymphoblastic leukemia: a collaborative Pediatric Oncology Branch, NCI, and Children's Cancer Group study.
Cancer chemotherapy and pharmacology 2001;47(3):199-205.
2001: Russell W Chesney; Peter Charles Adamson; T Wells; J T Wilson; Philip Walson
The testing of antihypertensive medications in children: report of the Antihypertensive Agent Guidelines Subcommittee of the Pediatric Pharmacology Research Units.
Pediatrics 2001;107(3):558-61.
2001: Elizabeth Fox; RF Murphy; Cynthia McCully; Peter Charles Adamson
Plasma pharmacokinetics and cerebrospinal fluid penetration of hypericin in nonhuman primates.
Cancer chemotherapy and pharmacology 2001;47(1):41-4.
2000: Carlos Longui; Alessandra Vottero; Peter Charles Adamson; D E Cole; Tomoshige Kino; Osmar Monte; George Chrousos
Low glucocorticoid receptor alpha/beta ratio in T-cell lymphoblastic leukemia.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2000;32(10):401-6.
2000: BRIGITTE WIDEMANN; E Sung; L Anderson; Wanda L Salzer; FRANK BALIS; K S Monitjo; Cynthia McCully; M Hawkins; Peter Charles Adamson
Pharmacokinetics and metabolism of the methotrexate metabolite 2, 4-diamino-N(10)-methylpteroic acid.
The Journal of pharmacology and experimental therapeutics 2000;294(3):894-901.
2000: Katherine E Warren; Joseph A Frank; J L Black; R S Hill; Jeff H Duyn; Alberta Aikin; Bobbi K Lewis; Peter Charles Adamson; FRANK BALIS
Proton magnetic resonance spectroscopic imaging in children with recurrent primary brain tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(5):1020-6.
1999: FRANK BALIS; Peter Charles Adamson
Application of pharmacogenetics to optimization of mercaptopurine dosing.
Journal of the National Cancer Institute 1999;91(23):1983-5.
1999: Brenda Joyce Kitchen; Ann B Moser; E Lowe; FRANK BALIS; BRIGITTE WIDEMANN; L Anderson; J Strong; Susan M Blaney; Stacey L Berg; Michelle O'Brien; Peter Charles Adamson
Thioguanine administered as a continuous intravenous infusion to pediatric patients is metabolized to the novel metabolite 8-hydroxy-thioguanine.
The Journal of pharmacology and experimental therapeutics 1999;291(2):870-4.
1999: BRIGITTE WIDEMANN; FRANK BALIS; Peter Charles Adamson
Dihydrofolate reductase enzyme inhibition assay for plasma methotrexate determination using a 96-well microplate reader.
Clinical chemistry 1999;45(2):223-8.
1999: A M Moser; Peter Charles Adamson; Andrea Gillespie; David G Poplack; FRANK BALIS
Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Cancer 1999;85(2):511-6.
1999: BRIGITTE WIDEMANN; FRANK BALIS; Karen Godwin; Cynthia McCully; Peter Charles Adamson
The plasma pharmacokinetics and cerebrospinal fluid penetration of the thymidylate synthase inhibitor raltitrexed (Tomudex) in a nonhuman primate model.
Cancer chemotherapy and pharmacology 1999;44(6):439-43.
1998: G Thomas Budd; Peter Charles Adamson; M Gupta; P Homayoun; S K Sandstrom; R F Murphy; D McLain; L Tuason; David M Peereboom; Ronald M Bukowski; Ram Ganapathi
Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(3):635-42.
1998: Susan M Blaney; Michael Neil Needle; Andrea Gillespie; J K Sato; Gregory H Reaman; Stacey L Berg; Peter Charles Adamson; Mark Krailo; Archie Bleyer; David G Poplack; FRANK BALIS
Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(2):357-60.
1998: Stacey L Berg; Susan M Blaney; Peter Charles Adamson; Michelle O'Brien; David G Poplack; Carola A S Arndt; Julie Blatt; FRANK BALIS
Phase I trial and pharmacokinetic study of pyrazoloacridine in children and young adults with refractory cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):181-6.
1997: Peter Charles Adamson; Gregory Reaman; Jerry Z Finklestein; James Feusner; Stacey L Berg; Susan M Blaney; Michelle O'Brien; RF Murphy; FRANK BALIS
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3330-7.
1997: Brenda Joyce Kitchen; FRANK BALIS; David G Poplack; Michelle O'Brien; C E Craig; Peter Charles Adamson
A pediatric phase I trial and pharmacokinetic study of thioguanine administered by continuous i.v. infusion.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(5):713-7.
1997: BRIGITTE WIDEMANN; FRANK BALIS; RF Murphy; JM Sorensen; MJ Montello; Michelle O'Brien; Peter Charles Adamson
Carboxypeptidase-G2, thymidine, and leucovorin rescue in cancer patients with methotrexate-induced renal dysfunction.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):2125-34.
1997: Susan M Blaney; Nita L Seibel; Michelle O'Brien; Gregory H Reaman; Stacey L Berg; Peter Charles Adamson; David G Poplack; Mark Krailo; Revonda B Mosher; FRANK BALIS
Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(4):1538-43.
1996: Susan M Blaney; Peter C Phillips; R J Packer; Richard L Heideman; Stacey L Berg; Peter Charles Adamson; J C Allen; Stephen E Sallan; R I Jakacki; Beverly J Lange; Gregory H Reaman; M E Horowitz; David G Poplack; FRANK BALIS
Phase II evaluation of topotecan for pediatric central nervous system tumors.
Cancer 1996;78(3):527-31.
1996: AS O'Marcaigh; C M Johnson; W A Smithson; M C Patterson; BRIGITTE WIDEMANN; Peter Charles Adamson; M J McManus
Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.
Mayo Clinic proceedings. Mayo Clinic 1996;71(2):161-5.
1995: Peter Charles Adamson; FRANK BALIS; J E Belasco; B Lange; Stacey L Berg; Susan M Blaney; C Craig; David G Poplack
A phase I trial of amifostine (WR-2721) and melphalan in children with refractory cancer.
Cancer research 1995;55(18):4069-72.
1995: BRIGITTE WIDEMANN; M L Hetherington; RF Murphy; FRANK BALIS; Peter Charles Adamson
Carboxypeptidase-G2 rescue in a patient with high dose methotrexate-induced nephrotoxicity.
Cancer 1995;76(3):521-6.
1995: J Bailey; James M Pluda; A Foli; MW Saville; S Bauza; Peter Charles Adamson; RF Murphy; R B Cohen; S Broder; Robert Yarchoan
Phase I/II study of intermittent all-trans-retinoic acid, alone and in combination with interferon alfa-2a, in patients with epidemic Kaposi's sarcoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(8):1966-74.
1995: Peter Charles Adamson; J Bailey; James M Pluda; David G Poplack; S Bauza; RF Murphy; Robert Yarchoan; FRANK BALIS
Pharmacokinetics of all-trans-retinoic acid administered on an intermittent schedule.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(5):1238-41.
1995: Peter Charles Adamson; RF Murphy; Karen Godwin; E H Ulm; FRANK BALIS
Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey.
Cancer research 1995;55(3):482-5.
1994: Peter Charles Adamson
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Leukemia 1994;8(11):1813-6.
1994: Peter Charles Adamson; David G Poplack; FRANK BALIS
The cytotoxicity of thioguanine vs mercaptopurine in acute lymphoblastic leukemia.
Leukemia research 1994;18(11):805-10.
1994: Peter Charles Adamson
Pharmacokinetics of all-trans-retinoic acid: clinical implications in acute promyelocytic leukemia.
Seminars in hematology 1994;31(4 Suppl 5):14-7.
1994: Shai Izraeli; Peter Charles Adamson; Susan M Blaney; FRANK BALIS
Acute pancreatitis after ifosfamide therapy.
Cancer 1994;74(5):1627-8.
1994: Peter Charles Adamson
Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Leukemia 1994;8 Suppl 3():S22-5.
1993: H C Pitot; J Rubin; J S Kovach; A J Schutt; Peter Charles Adamson
all-trans retinoic acid: a dose-seeking study in solid tumors.
Annals of the New York Academy of Sciences 1993;691():250-2.
1993: Peter Charles Adamson; FRANK BALIS; Mary E Hawkins; RF Murphy; David G Poplack
Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells.
Biochemical pharmacology 1993;46(9):1627-36.
1993: Peter Charles Adamson; H C Pitot; FRANK BALIS; J Rubin; RF Murphy; David G Poplack
Variability in the oral bioavailability of all-trans-retinoic acid.
Journal of the National Cancer Institute 1993;85(12):993-6.
1993: Susan M Blaney; J L Grem; FRANK BALIS; D E Cole; Peter Charles Adamson; David G Poplack
Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
Biochemical pharmacology 1993;45(7):1493-501.
1993: Peter Charles Adamson; J F Boylan; FRANK BALIS; RF Murphy; Karen Godwin; L J Gudas; David G Poplack
Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
Cancer research 1993;53(3):472-6.
1992: Malcolm A Smith; Peter Charles Adamson; FRANK BALIS; J Feusner; L Aronson; RF Murphy; M E Horowitz; Gregory Reaman; G D Hammond; R M Fenton
Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1666-73.
1992: Peter Charles Adamson; FRANK BALIS; Malcolm A Smith; RF Murphy; Karen Godwin; David G Poplack
Dose-dependent pharmacokinetics of all-trans-retinoic acid.
Journal of the National Cancer Institute 1992;84(17):1332-5.
1992: Peter Charles Adamson; FRANK BALIS; Cynthia McCully; K S Godwin; David G Poplack
Methotrexate pharmacokinetics following administration of recombinant carboxypeptidase-G2 in rhesus monkeys.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(8):1359-64.
1992: Susan M Blaney; FRANK BALIS; J Grem; D E Cole; Peter Charles Adamson; David G Poplack
Modulation of the cytotoxic effect of cyclopentenylcytosine by its primary metabolite, cyclopentenyluridine.
Cancer research 1992;52(12):3503-5.
1992: Peter Charles Adamson; FRANK BALIS; J Miser; Carola A S Arndt; R J Wells; A Gillespie; L Aronson; J S Penta; N J Clendeninn; David G Poplack
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.
Cancer research 1992;52(3):521-4.
1992: Peter Charles Adamson; S Zimm; A H Ragab; FRANK BALIS; Seth M Steinberg; Barton A. Kamen; Teresa J Vietti; A Gillespie; David G Poplack
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia.
Cancer chemotherapy and pharmacology 1992;30(2):155-7.
1991: Peter Charles Adamson; FRANK BALIS; Carola A S Arndt; J S Holcenberg; P K Narang; RF Murphy; A J Gillespie; David G Poplack
Intrathecal 6-mercaptopurine: preclinical pharmacology, phase I/II trial, and pharmacokinetic study.
Cancer research 1991;51(22):6079-83.
1991: Peter Charles Adamson; FRANK BALIS; Cynthia McCully; K S Godwin; J D Bacher; THOMAS WALSH; David G Poplack
Rescue of experimental intrathecal methotrexate overdose with carboxypeptidase-G2.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(4):670-4.
1991: Peter Charles Adamson; M E Horowitz; David G Poplack
The child with recurrent solid tumor.
Pediatric clinics of North America 1991;38(2):489-504.
1990: Peter Charles Adamson; FRANK BALIS; S M Steinberg; David G Poplack; J S Holcenberg
Pharmacokinetics of mercaptopurine in children with acute lymphocytic leukemia.
The New England journal of medicine 1990;323(22):1565-6.
1990: Peter Charles Adamson; David G Poplack; FRANK BALIS
Pharmacology and drug resistance in childhood lymphoblastic leukemia.
Hematology/oncology clinics of North America 1990;4(5):871-94.
1990: Peter Charles Adamson; FRANK BALIS; J Miser; R J Wells; Archie Bleyer; T E Williams; A Gillespie; J S Penta; N J Clendeninn; David G Poplack
Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule.
Cancer research 1990;50(15):4464-7.
1990: Peter Charles Adamson; S Zimm; A H Ragab; Seth M Steinberg; FRANK BALIS; Barton A. Kamen; Teresa J Vietti; A Gillespie; David G Poplack
A phase II trial of continuous-infusion 6-mercaptopurine for childhood solid tumors.
Cancer chemotherapy and pharmacology 1990;26(5):343-4.
1989: Peter Charles Adamson; T C Wu; Bruce D Meade; M Rubin; C R Manclark; PA Pizzo
Pertussis in a previously immunized child with human immunodeficiency virus infection.
The Journal of pediatrics 1989;115(4):589-92.
1989: Peter Charles Adamson; M G Rinaldi; PA Pizzo; THOMAS WALSH
Amphotericin B in the treatment of Candida cholecystitis.
The Pediatric infectious disease journal 1989;8(6):408-11.